Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Treatment of heparin-induced thrombocytopenia: a critical review Hirsh J; Heddle N; Kelton JGArch Intern Med 2004[Feb]; 164 (4): 361-9Heparin-induced thrombocytopenia (HIT) is a serious complication of heparin therapy that has a high rate of morbidity (thrombosis and amputation) and mortality. In the past, a number of different anticoagulants have been used to treat HIT in an attempt to prevent these complications. More recently, direct thrombin inhibitors have become popular. This systematic review summarizes the risk for thrombosis in HIT patients when heparin therapy is stopped; evidence of the efficacy of thrombin inhibitors in patients with HIT with and without thrombosis; evidence supporting the use of thrombin inhibitors in patients with a history of HIT who require a coronary intervention procedure; and the risk for bleeding when antithrombotic agents are used.|Anticoagulants/adverse effects/*therapeutic use[MESH]|Arginine/analogs & derivatives[MESH]|Heparin/adverse effects[MESH]|Hirudins/*analogs & derivatives[MESH]|Humans[MESH]|Pipecolic Acids/*therapeutic use[MESH]|Recombinant Proteins/*therapeutic use[MESH]|Risk Assessment[MESH]|Sulfonamides[MESH]|Thrombocytopenia/chemically induced/*drug therapy[MESH]|Thrombosis/etiology[MESH] |
